survey
frequenc
report
infect
target
autoantigen
guillain
barr
syndrom
gb
patient
detect
antibodi
myelin
microb
sulfatid
cardiolipin
gd
sgpg
iiyo
iiyo
antibodi
frequent
detect
heterogen
autoantibodi
wide
spectrum
antimicrobi
igg
igm
antibodi
also
detect
murnpsspecif
igg
yo
ad
e
n
ovi
r
u
p
e
c
c
g
g
yo
varicellazost
virusspecif
igg
pneumonia
serotyp
igg
preval
result
indic
polyclon
expans
physiolog
patholog
antibodi
andor
molecular
mimicri
like
occur
follow
infect
relat
autoimmun
factor
etiolog
gb
although
singl
definit
myelinspecif
autoantibodi
identifi
result
suggest
uniqu
pattern
reactiv
autoantigen
wileyliss
inc
guillainbarrc
syndrom
gb
transient
neurolog
disord
character
areflex
motor
paralysi
mild
sensori
disturb
conjunct
acellular
rise
total
protein
cerebrospin
fluid
associ
inflammatori
demyelin
peripher
nerv
although
pathogenesi
gb
fulli
elucid
increas
evid
point
autoimmun
etiolog
autoantibodi
variou
myelinassoci
glycoconjug
describ
gb
patient
howev
primari
autoantigen
gb
yet
clearli
identifi
moreov
yet
fulli
determin
whether
autoantibodi
associ
gb
directli
involv
pathogenesi
nerv
damag
induc
demyelin
releas
autoantigen
via
tcellmedi
inflammatori
reaction
success
treatment
gb
patient
plasmapheresi
intraven
gammaglobulin
ivig
support
notion
circul
myelin
autoantibodi
could
play
direct
role
pathogenesi
myelinspecif
antibodi
potenti
use
diagnosi
predict
treatment
success
either
plasmapheresi
prior
infect
often
associ
gb
although
ident
pathogen
relationship
ivig
subsequ
onset
neurolog
diseas
remain
uncertain
pathogen
reportedli
associ
gb
includ
herp
virus
hsv
epsteinbarr
viru
ebv
cytomegaloviru
cmv
human
varicellazost
viru
vzv
human
tcell
lymphotroph
virus
htlv
human
immunodefici
virus
hiv
measl
coxsackieviru
rubella
mump
influenza
hepat
virus
mycoplasma
pneumonia
rorrelia
burgdocferi
respiratori
syncyti
viru
campylobact
jejuni
echoviru
coronaviru
parainfluenza
streptococcu
enteroviru
parvoviru
studi
survey
sera
csf
gb
patient
presenc
antibodi
myelin
autoantigen
includ
gangliosid
galactosyl
cerebrosid
sulfat
glycolipid
forssman
antigen
myelin
basic
protein
mbp
cardiolipin
sequenc
similar
exist
bacteria
virus
neuron
autoantigen
studi
analyz
associ
bsa
undilut
csf
specimen
ad
well
incub
h
rt
follow
repeat
wash
bound
antibodi
detect
ad
goat
antihuman
igm
andor
antihuman
igg
conjug
alkalin
phosphatas
dilut
paranitrophenyl
phosphat
optic
densiti
od
read
nm
automat
micropl
reader
presenc
myelin
autoantibodi
antibodi
common
infecti
agent
known
associ
gb
studi
also
attempt
identifi
possibl
pattern
autoantibodi
pathogenspecif
antibodi
reactiv
addit
use
novel
flow
cytometri
assay
detect
neuron
antibodi
sera
obtain
gb
patient
nation
institut
neurolog
diseas
stroke
diagnost
criteria
white
male
white
femal
age
year
diagnosi
within
median
period
week
onset
neurolog
symptom
age
gender
racematch
normal
diseas
control
sera
collect
healthi
subject
patient
clinic
definit
multipl
sclerosi
ms
poser
criteria
patient
idiopath
transvers
myeliti
tm
jefferi
criteria
patient
chronic
inflammatori
demyelin
polyradiculoneuropathi
cidp
uncini
criteria
patient
polyneuropathi
pn
pestronk
criteria
patient
chronic
fatigu
immun
dysfunct
syndrom
cfid
cdc
criteria
csf
specimen
obtain
gb
patient
control
individu
without
evid
neuroborreliosi
glycolipid
antigen
galactosyl
cerebrosid
galcer
sulfatid
ceramid
galactosid
sgpg
sulfoglucuronyl
paraglobosid
sphingomyelin
cardiolipin
forssman
antigen
monosialogangliosid
gmi
gm
disialogangliosid
gd
gd
gdj
trisialogangliosid
gtlb
asialogm
myelin
glycoprotein
antigen
myelin
basic
protein
mbp
myclinassoci
glycoprotein
mag
use
determin
autoantibodi
sera
csf
sgpg
mbp
mag
antigen
prepar
extract
chromatographi
myelin
antigen
purchas
matreya
pleasant
gap
pa
antibodi
myelin
glycoconjug
determin
enzymelink
immunosorb
assay
eia
ngwell
appropri
myelin
antigen
dissolv
chloroform
methanol
vv
coat
evapor
flatbottom
plate
immulon
mbp
mag
antigen
mm
ph
ngwell
coat
h
uncoat
well
background
fill
coat
solut
well
block
phosphatebuff
salinei
bovin
serum
albumin
bsa
min
rt
wash
pbst
mm
sodium
phosphat
mm
nacl
ph
total
pl
test
sera
posit
control
dilut
specif
antibodi
infecti
agent
detect
follow
gener
eia
procedur
antigen
ngwell
mm
carbon
buffer
ph
coat
onto
immulon
dynatech
chantilli
va
polysorp
nunc
napervil
il
polystyren
microtit
plate
overnight
c
decant
wash
pbst
block
bsafor
min
rt
standard
control
test
sera
dilut
bsa
pipet
duplic
well
incub
h
rt
shaker
follow
repeat
wash
bound
antibodi
detect
ad
goat
antihuman
antihuman
igg
conjug
alkalin
phosphatas
dilut
paranitrophenyl
phosphat
optic
densiti
od
read
nm
automat
micropl
reader
repres
sera
posit
eia
myelin
compon
reactiv
analyz
tlc
total
pl
gtlb
galcer
aliquot
mgml
stock
solut
make
glycolipid
cocktail
l
pl
gm
gdlb
gd
asialogm
sulfatid
sgpg
aliquot
mgml
stock
solut
make
glycolipid
cocktail
pl
cocktail
spot
duplic
x
cm
aluminumback
silica
gel
plate
aldrich
milwauke
wi
air
dri
develop
v
v
chloroform
plate
air
dri
briefli
immers
polyisobutylmethacryl
nhexan
thorough
dri
fix
plate
block
bsa
min
wash
min
pb
immers
dilut
appropri
serum
specimen
bsa
incub
overnight
rocker
plate
wash
three
time
min
pb
incub
goat
antihuman
iggbiotin
goat
antihuman
igmbiotin
conjug
chemicon
temecula
ca
h
rt
wash
plate
incub
streptavidinhorseradish
peroxidas
h
rt
wash
develop
diaminobenzidin
substrat
mm
ph
tlc
valid
glycolipid
migrat
valu
rf
parallel
plate
individu
glycolipid
per
lane
colorimetr
stain
orcinol
gangliosid
azur
sulfoglycolipid
human
neuroblastoma
cell
line
sknmc
sknsh
americantyp
cultur
collect
atcc
rockvil
md
use
sourc
antigen
neuron
cell
line
maintain
rpmi
medium
supplement
fetal
calf
serum
air
confluent
cell
harvest
wash
twice
isotonicbuff
salin
edta
solut
bss
resuspens
cell
count
cell
concentr
adjust
optim
concentr
determin
block
titrat
nonspecif
bind
site
block
incub
cell
bss
contain
goat
serum
incub
cell
repeatedli
wash
resuspend
bss
pl
aliquot
cell
suspens
dispens
incub
tube
pl
dilut
sera
ad
tube
cell
incub
repeatedli
wash
stain
fitclabel
goat
antihuman
igg
conjug
wash
cell
resuspend
bss
analyz
epic
profil
flow
cytomet
mean
intens
fluoresc
mif
use
logarithm
scale
determin
sampl
cutoff
valu
defin
mean
standard
deviat
mif
unit
use
frequenc
distribut
curv
healthi
control
sera
confid
limit
mifunit
statist
analys
includ
test
normal
distribut
student
ttest
spearman
rank
correl
accuraci
precis
eia
run
estim
use
normal
establish
cutoff
mean
sd
correct
valu
p
consid
signific
ttest
analys
rs
valu
spearman
rank
correl
test
interassay
coeffici
variat
cv
cutoff
valu
glycolipid
antibodi
eia
microbespecif
antibodi
eia
variou
autoantibodi
detect
sera
csf
gb
patient
tabl
none
antibodi
alon
could
consid
diagnost
reactiv
cardiolipin
sulfatid
gd
frequent
detect
antibodi
gb
sera
follow
gm
gm
sgpg
antibodi
none
healthi
control
antibodi
autoantigen
neuron
antibodi
detect
gb
patient
sera
overal
gb
patient
sera
least
one
antibodi
one
myelin
autoantigen
reactiv
five
autoantigen
note
least
six
sera
autoantigen
tabl
multireact
autoantigen
found
csf
specimen
gb
patient
tabl
gb
csf
specimen
react
gd
antigen
react
autoantigen
specif
csf
reactiv
confirm
control
csf
individu
without
evid
neuroborreliosi
none
control
specimen
reactiv
myelin
compon
repres
sera
posit
autoantibodi
myelin
compon
eia
confirm
tlc
immunofix
sera
test
multireact
eia
multireact
confirm
tlc
band
detect
r
fig
also
detect
gb
patient
sera
multireact
pattern
igg
igm
microbespecif
antibodi
also
observ
gb
sera
antibodi
mani
infecti
agent
tabl
eight
patient
lack
antibodi
microorgan
variou
level
signific
sera
multireact
autoantigen
microb
establish
spearman
rank
correl
tabl
signific
relat
mump
igg
sulfatid
antibodi
illustr
see
fig
linear
regress
analysi
one
patient
glycolipid
autoantibodi
antibodi
c
jejuni
wherea
anoth
patient
one
autoantibodi
antibodi
eight
differ
microorgan
tabl
major
autoantibodi
low
titer
polyreact
fig
although
higher
affin
autoantibodi
perhap
increas
specif
pathogen
also
detect
determin
whether
transient
sulfatid
autoantibodi
present
mump
iggposit
sera
individu
without
gb
clinic
autoimmun
diseas
control
mump
iggposit
sera
test
sulfatid
antibodi
eighteen
percent
control
mump
iggposit
sera
posit
sulfatid
antibodi
data
shown
preincub
yg
sulfatid
gb
control
mumpsposit
sera
inhibit
bind
mump
antigenco
plate
gb
acut
condit
usual
resolv
within
day
week
respond
immunomodul
ivig
iggclear
modal
plasmapheresi
last
three
decad
ampl
inform
indic
gb
could
autoimmun
etiopathogenesi
wide
discrep
variat
report
type
bind
characterist
autoantibodi
associ
gb
potenti
infecti
caus
diseas
autoantibodi
report
gb
includ
mainli
antibodi
gangliosid
gm
gd
conserv
epitop
could
also
distribut
organ
system
nervou
system
current
evid
support
notion
singl
gb
antigen
likewis
multipl
anteced
factor
ie
infecti
agent
diseas
differ
myelin
antigen
might
relat
term
sequenti
conform
homolog
variou
pathogen
molecular
mimicri
gb
also
occur
associ
autoimmun
diseas
neurolog
overlap
syndrom
although
autoantibodi
cardiolipin
gd
sulfatid
sgpg
detect
higher
frequenc
sera
gb
patient
none
autoantibodi
exclu
glycolipid
antibodi
usual
confirmatori
neuropathi
nervou
system
inflamm
neuropsychiatr
involv
high
titer
sulfatid
antibodi
defin
give
clinic
specif
cutoff
detect
gb
patient
studi
high
specif
csf
gd
antibodi
support
diagnost
util
gd
antibodi
sever
gb
evalu
clinic
specif
antibodi
progress
reactiv
gb
sera
myelin
autoantigen
evalu
suggest
uniqu
pattern
myelinspecif
antibodi
result
suggest
multiinfecti
etiolog
gb
increas
suscept
gb
patient
infect
illustr
difficulti
determin
whether
infect
specif
organ
trigger
diseas
individu
patient
interestingli
recent
report
describ
patient
recurr
gb
preced
differ
infect
report
predomin
upper
respiratori
gastrointestin
tract
infect
gb
patient
confirm
studi
pathogen
variou
tissu
specif
detect
gb
patient
evalu
result
indic
autoantibodi
screen
potenti
use
earli
detect
autoimmun
diseas
onset
follow
certain
infect
especi
mump
cmv
hsv
pneurnonia
vzv
adenoviru
c
jejuni
influenza
ab
tabl
patient
certain
autoimmun
disord
test
appropri
infecti
diseas
appropri
autoantigen
infecti
agent
test
advis
insulindepend
diabet
mellitu
mump
cmv
coxsackievirus
l
lo
syndenham
chorea
chaga
diseas
myocard
trypanosorna
cruzi
cmv
reactiv
rheumatoid
arthriti
streptococcu
yersinia
klebsiella
multipl
sclerosi
measl
rubella
varicellazost
mrz
reaction
believ
gb
cellular
humor
autoimmun
diseas
induc
infect
multipl
microorgan
presenc
microbespecif
antibodi
cell
crossreact
variou
nervesheath
compon
initi
inflammatori
demyelin
shed
peripher
nerv
autoantigen
infect
result
polyclon
expans
elev
physiolog
autoantibodi
concentr
presenc
cytokineinduc
antigen
present
cell
eg
schwann
cell
autoantigen
present
immun
system
lead
secondari
tcell
mediat
activ
togeth
loss
toler
bcell
prolifer
autospecif
affin
matur
could
respons
progress
sometim
chronic
chang
dysfunct
gb
patient
autoantibodi
also
caus
prolifer
activ
cell
dosedepend
manner
idiotyp
network
tertiari
suppressor
tcell
respons
note
spontan
recoveri
sive
use
diagnost
paramet
detect
patient
interestingli
l
l
patient
sera
react
five
structur
divers
autoantigen
mbp
gangliosid
sulfatid
pattern
glycolipid
crossandor
polyreact
also
note
igm
paraproteinemia
associ
polyneuropathi
amyotroph
later
sclerosi
gb
patient
sera
react
one
myelin
antigen
highest
frequenc
reactiv
observ
cardiolipin
sulfatid
find
gb
csf
specimen
reactiv
gd
autoantigen
respect
indic
csf
might
appropri
specimen
evalu
gb
suggest
possibl
sequestr
circul
autoantibodi
central
nervou
system
andor
intrathec
synthesi
immunoglobulin
howev
csf
myelin
antibodi
titer
low
specimen
polyreact
elev
csf
myelin
antibodi
rel
sera
previous
describ
neuroborreliosi
chronic
inflammatori
demyelin
polyneuropathi
gb
gb
sera
also
show
wide
spectrumof
microbespecif
reactiv
inde
igm
antibodi
detect
common
well
infrequ
infect
patient
exampl
c
jejunispecif
igm
detect
patient
wherea
igm
antibodi
mump
vzv
cmv
andm
pneurnonia
detect
patient
furthermor
high
titer
igg
antibodi
detect
patient
high
correl
mump
sulfatid
reactiv
well
specif
mump
reactiv
suggest
polyclon
activ
lymphocyt
mump
infect
pathogen
mechan
rather
true
crossreact
work
immunoaffin
fraction
mumpsposit
sera
progress
current
much
discrep
literatur
concern
clinic
analyt
ie
endpoint
titrat
versu
concentr
auk
specif
sensit
sulfatid
antibodi
depend
method
detect
sulfatid
antibodi
report
gb
patient
preval
sulfatid
antibodi
neurolog
immunolog
autoimmun
diseas
healthi
control
emphas
current
uncertainti
clinic
util
sulfatid
antibodi
detect
definit
cohort
studi
acut
convalesc
specimen
need
assess
whether
detect
natur
sulfatid
autoantibodi
predispos
patient
neuropathi
autoimmun
diseas
whether
low
titer
progress
elev
patholog
level
antibodi
avid
studi
j
also
requir
discrimin
natur
pathogen
sulfatid
antibodi
similar
problem
interlaboratori
assay
standard
definit
assay
cutoff
differ
diagnost
categor
well
patient
control
select
criteria
report
gm
antibodi
motor
neuron
diseas
howev
high
titer
andor
high
activ
sulfatid
cardiolipin
experiment
demyelin
well
apoptosi
secondari
primari
cell
induct
antiidiotyp
antibodi
gangliosideinduc
immunosuppress
lymphocyt
institut
earli
plasmapheresi
ivlg
interfer
progress
diseas
promot
recoveri
although
instanc
plasmapheresi
ivig
contraind
corticosteroid
treatment
effect
case
work
synergist
ivig
